A recent overhaul in the U.S. childhood immunisation schedule has moved vaccines for hepatitis A, hepatitis B, and rotavirus out of the routine category, igniting controversy among health officials and paediatricians about its impact on child health and vaccine uptake.
A quiet but far-reaching change to the U.S. childhood vaccination framework has set off a fierce dispute between federal officials and paediatricians. According to reporting from The Hearty Soul, the CDC’s updated schedule moved hepatitis A, hepatitis B and rotavirus out of the routine category, alongside several other vaccines that are now subject to shared clinical decision-making rather than automatic recommendation. The shift matters because, over three decades, those three vaccines together are credited with preventing nearly 2 million hospitalisations and more than 90,000 deaths.
The CDC says its child and adolescent immunisation schedule is designed to guide clinicians through routine, risk-based and shared decision-making recommendations. In practice, however, moving a vaccine out of the universal tier can sharply reduce uptake, because families are less likely to seek out a shot that is no longer presented as standard care. The HHS fact sheet on the revised recommendations says the changes affect rotavirus, influenza, meningococcal disease, hepatitis A, hepatitis B and COVID-19, underscoring how broad the overhaul has become.
Rotavirus is one of the clearest examples of what is at stake. Before vaccination began in 2006, the virus sent tens of thousands of young children to hospital each year in the United States, and it could become dangerous very quickly in infants. CDC schedule materials still list rotavirus among the vaccines included for children, while the revised framework places it in the shared clinical decision-making category. That creates a practical concern: the vaccine must be given early in infancy to be effective, so delays in discussion can mean lost protection.
The same tension applies to hepatitis B and hepatitis A. Hepatitis B can cause chronic infection, liver failure and liver cancer, and the birth dose has long been used to protect babies whose maternal risk is not fully known at delivery. Hepatitis A, by contrast, spreads through contaminated food, water and close contact, and children can pass it on without obvious symptoms. The CDC’s schedule pages continue to include both vaccines, but the updated policy means they are no longer treated as universal defaults in the way they once were.
Meningococcal disease remains especially alarming because it can progress with extraordinary speed and carries a high risk of death or permanent disability. Public health data cited in the article notes that U.S. cases have risen recently, including a 2023 total that was the highest since 2014, and the CDC issued a health advisory in 2024 over increasing serogroup Y infections. Against that backdrop, paediatricians have argued that pushing the vaccine away from routine status is difficult to square with current risk. Influenza and COVID-19 now sit in the same shared-decision bucket, even though children under 5 remain among the most vulnerable to severe flu outcomes and COVID-19 still poses greater risks for children with underlying conditions.
The American Academy of Pediatrics has taken the opposite approach, keeping these vaccines on its own 2026 schedule and continuing to recommend routine protection against 18 diseases. The association’s guidance has also been backed by more than 230 medical organisations, including the American Medical Association and the American College of Obstetricians and Gynecologists, according to the article. A federal judge in Boston later paused the CDC schedule changes, leaving their status contested, while insurance coverage is expected to continue through 2026. For parents, the central point is simple: the vaccines remain available, but the new federal framework has changed how strongly they are pushed, and that difference is likely to shape whether children actually receive them.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
